Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia

Metabolism: Clinical and Experimental

Volumn 49, Issue 9, 2000, Pages 1234-1238

  Dobs, A S ^a   Schrott, H ^a   Davidson, M H ^a   Bays, H ^a   Stein, E A ^a   Kush, D ^a   Wu, M ^a   Mitchel, Y ^a   Illingworth, R D ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LUTEINIZING HORMONE; MEVINOLIN; PLACEBO; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SIMVASTATIN; TESTOSTERONE; TETRACOSACTIDE; TRIACYLGLYCEROL;

ADRENAL GLAND; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MEGADOSE; GONAD; HUMAN; HYPERCHOLESTEROLEMIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROIDOGENESIS;

EID: 0033812189     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.7716a     Document Type: Article

References (31)

1. National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel II)
2. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients
3. Efficacy and six-month safety of simvastatin 80 mg/day: Results from the Worldwide Simvastatin Expanded Dose Program
4. Receptor mediated uptake of lipoprotein cholesterol and its utilization for steroid synthesis in the adrenal cortex
5. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic cells
6. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia
7. Impaired cortisol secretion in abetalipoproteinemia
8. The genetic relationship of abetalipoproteinemia and hypobetalipoproteinemia: A report of occurrence of both diseases within the same family
9. The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia
10. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway
11. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin)
12. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin
13. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads
14. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
15. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
16. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients
17. The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day
18. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
19. Cortisol secretion in patients on simvastatin
20. Effects of inhibition of cholesterol synthesis by simvastatin on the production of adrenocortical steroid hormones and ACTH. Clin Endocrinol (Oxf)
21. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin
22. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia
23. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin
24. Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolemia
25. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results
26. Randomized clinical trial of testosterone replacement therapy in hypogonadal men
27. Effects of testosterone supplementation in the aging male
28. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study
29. Is routine endocrine testing of important men necessary?
30. Improvement of sexual function in testosterone-deficient men treated for one year with a permeation-enhanced transdermal testosterone delivery system
31. Changes in erectile responsiveness during androgen replacement therapy